middle.news
Why Is Noxopharm Extending Convertible Notes and Securing New Loans?
8:39am on Tuesday 23rd of September, 2025 AEST
•
Biotechnology
Read Story
Why Is Noxopharm Extending Convertible Notes and Securing New Loans?
8:39am on Tuesday 23rd of September, 2025 AEST
Key Points
Convertible note maturity extended to January 2027
Accrued interest of $327,000 to be paid in cash by January 2026
Additional 520,000 unlisted options granted to noteholders
Unsecured $1.25 million loan from Chairman’s investment entity
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Noxopharm (ASX:NOX)
OPEN ARTICLE